GLOBAL LEADERS Adjudication Sub-Study

CompletedOBSERVATIONAL
Enrollment

7,365

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

May 30, 2020

Conditions
Coronary Artery DiseasePlatelet-aggregation Inhibitors
Trial Locations (19)

3010

Inselspital Bern University Hospital, Bern

Unknown

Wilhelminenspital 1160, Vienna

Research centre Bonheiden 3204, Bonheiden

Research centre Charleroi 3202, Charleroi

Research centre Genk 3205, Genk

Research centre Hasselt 3203, Hasselt

Research centre Sofia, 9901, Sofia

Research centre Bad Nauheim 4902, Bad Nauheim

Research centre Essen 4903, Essen

Research centre Arezzo 3902, Arezzo

Research centre Ferrara 3905, Ferrara

Research centre Pavia 3903, Pavia

Research centre Terni 3909, Terni

Research centre Amsterdam 3104, Amsterdam

Research centre Rotterdam 3101, Rotterdam

Research centre Chrzanow 4802, Chrzanów

Research centre Dabrowa Gornicza 4801, Dąbrowa Górnicza

Research centre Krakov 4807, Krakow

Research centre Blackburn 4404, Blackburn

All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03231059 - GLOBAL LEADERS Adjudication Sub-Study | Biotech Hunter | Biotech Hunter